Gewählte Publikation:
Fink, M.
Major adverse cardiovascular events in patients with cancer treated with immune checkpoint inhibitors
Humanmedizin; [ Diplomarbeit ] Medizinische Universität Graz; 2025. pp. 54
[OPEN ACCESS]
FullText
- Autor*innen der Med Uni Graz:
- Betreuer*innen:
-
Moik Florian
-
Riedl Jakob
- Altmetrics:
- Abstract:
- Background: Patients with cancer treated with immune checkpoint inhibitors (ICI) are at risk of developing immune-related adverse events. Accumulating evidence shows that ICI therapy might progress inflammatory processes and cause atherosclerosis leading to major adverse cardiovascular events (MACE).